| Name | Title | Contact Details |
|---|
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
"At EMD Millipore, one of the top three investors in R&D in the Life Science Tools industry, we develop cutting-edge technologies and services for bioscience research and biopharmaceutical manufacturing. Innovation drives everything we do. And it’s reinforced by our collaborative culture, pioneering spirit and unwavering focus on the world’s most challenging human health issues. EMD Millipore, known outside North America as Merck Millipore, is part of the Merck Group, a global company with 40,000 employees in more than 60 countries. EMD Millipore is a division of Merck KGaA, Darmstadt, Germany."
Emerald Heights, sponsored by Emerald Communities, is a nonprofit 501(c)(3) senior housing and service organization that provides its residents programs to cultivate culture, vitality and independence. The community is a Type A Continuing Care Retirement Community (CCRC) that accommodates residents`changing needs throughout the aging process. Situated on 38 acres in the Education Hill area of Redmond, Wash., just 17 miles northeast of Seattle, Emerald Heights is an amenity-rich and resort-style senior living community, plus an assisted living facility and a Medicare-certified skilled nursing health center. The campus opened in 1992 to provide housing and service to people ages 55 and older in the aspects of independent, assisted living and skilled nursing.
Built around a portfolio of recognized brands, Golden Leaf Holdings Incorporate is one of the largest cannabis oil and solution providers in North America. The Company leverages a strong management team with cannabis and food industry experience to complement its expertise in the extracting, refining and selling of cannabis oil, edibles and flower products. The Company has developed a strong consumer brand portfolio (“Golden Brands”) that includes the Golden, Proper, Chalice Farms, Liberty Reach and Jackpot Seaweed brands. In addition to leading branded products, Golden Leaf also maintains a foothold in the Oregon retail dispensary market with its award-winning chain of Chalice Farms retail stores.
At DCHS, our mission is simple: to improve health every day. We are seeking providers to join our group who will share in our mission and help to cultivate our vision…to be the healthcare provider of choice for the communities we serve. Be an integral partner with one of the country`s top-ranked, most respected healthcare systems. As a system, DCHS is dedicated to purchasing the most advanced technology, operating state-of-the-art facilities and introducing new and innovative models of care. Vision, passion, perseverance, knowledge, skill, dedication, warmth, caring, technology, and people, have come together like a finely woven tapestry to create a healthcare experience for our patients that we call the Dickinson Difference.